Imaging of the ovine corpus luteum microcirculation with contrast ultrasound

Ultrasound in Medicine and Biology

Volumn 37, Issue 1, 2011, Pages 59-68

  Sboros, Vassilis ^a   Averkiou, M ^b   Lampaskis, M ^b   Thomas, D H ^a   Silva, N ^a   Strouthos, C ^b   Docherty, J ^a   McNeilly, A S ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF CYPRUS   (Cyprus)

Author keywords

Contrast imaging; Microbubble; Sheep ovary; SonoVue; Tracer kinetics; Ultrasound

Indexed keywords

CONTRAST IMAGING; MICRO-BUBBLE; SHEEP OVARY; SONOVUE; TRACER KINETICS; ULTRASOUND;

ANIMALS; HISTOLOGY; MICROCIRCULATION; ULTRASONICS; WOOL;

BLOOD VESSELS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORPUS LUTEUM; ECHOGRAPHY; ESTRUS CYCLE; EWE; FEMALE; HEMODYNAMICS; HISTOLOGY; IMAGE ANALYSIS; IMAGE ENHANCEMENT; INTERMETHOD COMPARISON; MICROVASCULARIZATION; NONHUMAN; PRIORITY JOURNAL; REPRODUCIBILITY;

ANIMALS; AREA UNDER CURVE; CONTRAST MEDIA; CORPUS LUTEUM; DINOPROST; ESTROUS CYCLE; FEMALE; HEMODYNAMICS; IMAGE PROCESSING, COMPUTER-ASSISTED; MICROCIRCULATION; PHOSPHOLIPIDS; REGRESSION ANALYSIS; SHEEP, DOMESTIC; SULFUR HEXAFLUORIDE;

EID: 78649942835     PISSN: 03015629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2010.10.013     Document Type: Article

References (57)

1. Arditi M., Frinking P.J.A., Zhou X., Rognin N.G. A new formalism for the quantification of tissue perfusion by the destruction-replenishment method in contrast ultrasound imaging. IEEE Trans Ultrason Ferroelectr Freq Control 2006, 53:1118-1229.
2. Averkiou M., Lampaskis M., Kyriakopoulou K., Skarlos D., Klouvas G., Strouthos C., Leen E. Quantification of tumor microvascularity with respiratory gated contrast-enhanced ultrasound for monitoring therapy. Ultrasound Med Biol 2010, 36:68-77.
3. Baird D.T., McNeilly A.S. Gonadotrophic control of follicular development and function during the oestrous cycle of the ewe. J Reprod Fertil 1981, Sl30:119-133.
4. Baird D.T., Swanston I.A., McNeilly A.S. Relationship between LH, FSH, and prolactin concentration and the secretion of androgens and estrogens by the preovulatory follicle in the ewe. Biol Reprod 1981, 24:1013-1025.
5. Correas J.M., Tranquart M.C.F., Helenon O. The kidney: Imaging with microbubble contrast agents. Ultrasound Q 2006, 22:53-66.
6. Dickson S.E., Bicknell R., Fraser H.M. Mid-luteal angiogenesis and function in the primate is dependent on VEGF. J Endocrinol 2001, 168:409-416.
7. Dueholm M., Lundorf E., Hansen E.S., Sørensen J.S., Ledertoug S., Olesen F. Magnetic resonance imaging and transvaginal ultrasonography for the diagnosis of adenomyosis. Fertil Steril 2001, 76:588-594.
8. Duncan W.C., Sweeting V.M., Cawood P., Illingworth P.J. Measurement of creatine-kinase activity and diagnosis of ectopic pregnancy. Br J Obstet Gynecol 1995, 102:233-237.
9. Farquhar C.M. Ectopic pregnancy. Lancet 2005, 366:583-591.
10. Fisher N.G., Christiansen P.C., Leong-Poi H., Jayaweera A.R., Lidner J.R., Kaul S. Myocardial and microcirculatory kinetics of BR14, a novel third-generation intravenous ultrasound contrast agent. J Am Coll Cardiol 2002, 39:530-537.
11. Fraser H.M., Lunn S.F. Angiogenesis and its control in the female reproductive system. Br Med Bull 2000, 56:787-797.
12. Fraser H.M., Dickson S.E., Lunn S.F., Wulff C., Morris K.D., Carroll V., Bicknell R. Suppression of luteal angiogenesis in the primate after neutralization of vascular endothelial growth factor. Endocrinology 2000, 141:995-1000.
13. Fraser H.M., Wilson H., Rudge J.S., Wiegand S.J. Single injections of vascular endothelial growth factor trap block ovulation in the macaque and produce a prolonged, dose-related suppression of ovarian function. J Clin Endocrinol Metab 2005, 90:1114-1122.
14. Fraser H.M., Duncan W.C. Regulation and manipulation of angiogenesis in the ovary and endometrium. Reprod Fertil Dev 2009, 21:377-392.
15. Girling J.E., Rogers P.A. Recent advances in endometrial angiogenesis research. Angiogenesis 2005, 8:89-99.
16. Gudmundsson P., Shahgaldi K., Winter R., Dencker M., Kitlinski M., Thorsson O., Ljunggren L., Willenheimer R. Parametric quantification of myocardial ischaemia using real-time perfusion adenosine stress echocardiography images, with SPECT as reference method. Clin Physiol Funct Imaging 2010, 30:30-42.
17. Horne A.W., van den Driesche S., King A.E., Burgess S., Myers M., Ludlow H., Lourenco P., Ghazal P., Williams A.R., Critchley H.O., Duncan W.C. Endometrial inhibin/activin beta-B subunit expression is related to decidualization and is reduced in tubal ectopic pregnancy. J Clin Endocrinol Metab 2008, 93:2375-2382.
18. Jayaweera A.R., Edwards N., Glasheen W.P., Villanueva F.S., Abbott R.D., Kaul S. In vivo myocardial kinetics of air-filled albumin microbubbles during myocardial contrast eecchocardiography. Comparison with radiolabeled red blood cells. Circ Res 1994, 74:1157-1165.
19. Jones G., Jenkinson C., Taylor N., Mills A., Kennedy S. Measuring quality of life in women with endometriosis: Tests of data quality, score reliability, response rate and scaling assumptions of the Endometriosis Health Profile Questionnaire. Hum Reprod 2006, 21:2686-2693.
20. Kaufmann B.A., Wei K., Lindner J.R. Contrast echocardiography. Curr Probl Cardiol 2007, 32:51-96.
21. Klibanov A.L., Rasche P.T., Hughes M.S., Wojdyla J.K., Galen K.P., Wible J.H., Brandenburger G.H. Detection of individual microbubbles of an ultrasound contrast agent: Fundamental and pulse inversion imaging. Acad Radiol 2002, 9:S279-S281.
22. Kohzuki M., Kanzaki T., Murata Y. Contrast-enhanced power Doppler sonography of malignant ovarian tumors using harmonic flash-echo imaging: Preliminary experience. J Clin Ultrasound 2005, 33:237-242.
23. Lampaskis M., Kyriakopoulou K., Skarlos D., Klouvas G., Strouthos C., Leen E., Averkiou M. Quantification of tumor microvascularity with respiratory gated contrast enhanced ultrasound for monitoring therapy. Ultrasound Med Biol 2010, 36:306-312.
24. Lassau N., Chami L., Benatsou B., Peronneau P., Roche A. Dynamic contrast-enhanced ultrasonography (DCE-US) with quantification of tumor perfusion: A new diagnostic tool to evaluate the early effects of antiangiogenic treatment. Eur Radiol Suppl 2007, 17(Suppl 6):F89-F98.
25. Lindner J.R., Song J., Jayaweera A.R., Sklenar J., Kaul S. Microvascular rheology of Definity microbubbles after intra-arterial and intravenous administration. J Am Soc Echocardiogr 2002, 15:396-403.
26. Main M.L., Goldman J.H., Grayburn P.A. Ultrasound contrast agents: Balancing safety versus efficacy. Exp Op Dr Safety 2009, 8:49-56.
27. Marret H., Brewer M., Giraudeau B., Tranquart F., Satterfield W. Assessment of cyclic changes of microvessels in ovine ovaries using SonoVue contrast-enhanced ultrasound. Ultrasound Med Biol 2006, 32:163-169.
28. McNeilly A.S., Fraser H.M. Effect of gonadotrophin-releasing hormone agonist-induced suppression of LH and FSH on follicle growth and corpus luteum function in the ewe. J Endocrinol 1987, 115:273-282.
29. McNeilly A.S., Crow W.J., Fraser H.M. Suppression of pulsatile luteinizing hormone secretion by gonadotrophin-releasing hormone antagonist does not affect episodic progesterone secretion or corpus luteum function in ewes. J Reprod Fertil 1992, 96:865-874.
30. McNeilly A.S., Crow W., Brooks J., Evans G. Luteinizing hormone pulses, follicle-stimulating hormone and control of follicle selection in sheep. J Reprod Fertil 1992, 99:5-19.
31. Ohtani M., Takase S., Wijayagunawardane M.P.B., Tetsuka M., Miyamoto A. Reprod 2004, 127:117-124.
32. Orden M.R., Jurvellin J.S., Kirkinen P.P. Kinetics of a US contrast agent in benign and malignant adnexal tumors. Radiology 2003, 226:405-410.
33. Quaia E. Microbubble ultrasound contrast agents: An update. Eur Radiol 2007, 17:1995-2008.
34. Porter M.B. Polycystic ovary syndrome: The controversy of diagnosis by ultrasound. Sem Reprod Med 2008, 26:241-251.
35. Redmer D.A., Doraiswamy V., Bortmen B.J., Fisher K., Joblonka-Shariff A., Grazul-Bilska A.T., Reynolds L.P. Evidence for a role of capillary pericytes in vascular growth of the developing ovine corpus luteum. Biol Reprod 2001, 65:879-889.
36. Ross J. Extracts from " Clinical Evidence" -pelvic inflammatory disease. BMJ 2001, 322:658-659.
37. Sboros V., Moran C.M., Anderson T., Pye S.D., Macleod I.C., Millar A.M., McDicken W.N. Evaluation of an experimental system for the in-vitro assessment of ultrasonic contrast agents. Ultrasound Med Biol 2000, 26:105-111.
38. Sboros V., Moran C.M., Pye S.D., McDicken W.N. Contrast agent stability: A continuous B-mode imaging approach. Ultrasound Med Biol 2001, 27:1367-1377.
39. Sboros V., MacDonald C.A., Pye S.D., Moran C.M., Gomatam J., McDicken W.N. The dependence of ultrasound contrast agents backscatter on acoustic pressure: Theory versus experiment. Ultrasonics 2002, 40:579-583.
40. Sboros V., Ramnarine K.V., Moran C.M., Pye S.D., McDicken W.N. Understanding the limitations of ultrasonic backscatter measurements from microbubble populations. Phys Med Biol 2002, 47:4287-4299.
41. Sboros V., Moran C.M., Pye S.D., McDicken W.N. The behaviour of individual contrast agent microbubbles. Ultrasound Med Biol 2003, 29:687-694.
42. Sboros V., Tang M.-X. The assessment of microvascular flow and tissue perfusion using ultrasound imaging. J Eng Med 2010, 224(H2):273-290.
43. Souza C.J.H., Campbell B.K., McNeilly A.S., Baird D.T. What the known phenotypes of the Booroola mutation can teach us about its mechanism of action. Reprod Suppl 2003, 61:361-370.
44. Souza C.H., Campbell B.K., McNeilly A.S., Baird D.T. Mechanisms of action of the principal prolific genes and their application to sheep production. Reprod Fertil Dev 2004, 16:395-401.
45. Strouthos C., Lampaskis M., Sboros V., McNeilly A., Averkiou M. Indicator dilution models for the quantification of microvascular blood flow with bolus administration of ultrasound contrast agents. IEEE Trans Ultrason Ferroelectr Freq Control 2010, 57:1296-1310.
46. Talu E., Powell R.L., Longo M.L., Dayton P.A. Needle size and injection rate impact microbubble contrast agent population. Ultrasound Med Biol 2008, 34:1182-1187.
47. Tang M.-X., Eckersley R.J., Noble J.A. Pressure-dependent attenuation with microbubbles at low mechanical index. Ultrasound Med Biol 2005, 31:377-384.
48. Tang M.-X., Eckersley R.J. Nonlinear propagation of ultrasound through microbubble contrast agents and implications for imaging. IEEE Trans Ultrason Ferroelectr Freq Control 2006, 53:2406-2415.
49. Tang M.-X., Eckersley R.J. Frequency and pressure dependent attenuation and scattering by microbubbles. Ultrasound Med Biol 2007, 33:164-168.
50. Testa A.C., Timmerman D., Exacoustos C., Fruscella E., Van Holsbeke C., Bokor D., Arduini D., Scambia G., Ferrandina G. The role of CnTI-SonoVue in the diagnosis of ovarian masses with papillary projections: a preliminary study. Ultrasound Obstet Gynecol 2007, 29:512-516.
51. Thomas D.H., Butler M.B., Anderson T., Steel R., Pye S.D., Poland M., Brock-Fisher T., McDicken W.N., Sboros V. Single microbubble response using pulse sequences: Initial results. Ultrasound Med Biol 2009, 35:112-119.
52. Thomas D.H., Looney P., Steel R., Pelekasis N., McDicken W.N., Anderson T., Sboros V. Acoustic detection of microbubble resonance. Appl Phys Lett 2009, 94:243902.
53. Vonnahme K.A., Redmer D.A., Borowczyk E., ilski J.J., Luther J.S., Johnson M.L., Reynolds L.P., Grazul-Bilska A.T. Vascular composition, apoptosis, and expression of angiogenic factors in the corpus luteum during prostaglandin F2alpha-induced regression in sheep. Reproduction 2006, 131:1115-1126.
54. Wulff C., Wilson H., Rudge J.S., Wiegand S.J., Lunn S.F., Fraser H.M. Luteal angiogenesis: Prevention and intervention by treatment with vascular endothelial growth factor trap A40. J Clin Endocrinol Metab 2001, 87:3377-3386.
55. Wulff C., Weigand S.J., Saunders P.T.K., Scobie G.A., Fraser H.M. Angiogenesis during follicular development in the primate and its inhibition by treatment with truncated Flt-1-Fc (vascular endothelial growth factor Trap A40). Endocrinology 2001, 142:3244-3254.
56. Wulff C., Wilson H., Wiegand S.J., Rudge J.S., Fraser H.M. Prevention of thecal angiogenesis, antral follicular growth, and ovulation in the primate by treatment with vascular endothelial growth factor trap R1R2. Endocrinology 2002, 143:2797-2807.
57. Yong P., Baird D.T., Thong J., McNeilly A.S., Anderson R.A. Prospective analysis of the relationships between the ovarian follicle cohort and basal FSH concentration, the inhibin response to exogenous FSH, ovarian follicle number at different stages of the normal menstrual cycle and after pituitary down-regulation. Hum Reprod 2003, 18:35-44.